Home / Markets / Capital Market News / Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Last Updated : Aug 13 2024 | 9:35 AM IST

Sales decline 3.45% to Rs 17.05 crore

Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as against Rs 0.11 crore during the previous quarter ended June 2023. Sales declined 3.45% to Rs 17.05 crore in the quarter ended June 2024 as against Rs 17.66 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales17.0517.66 -3 OPM %2.402.04 -PBDT0.430.33 30 PBT0.270.21 29 NP0.170.11 55

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content